Regulatory Service

Entering a vast field of pharmaceutical products into international markets requires a detailed understanding of complex regulatory requirements. Biozenta’s Drug Regulatory Affairs (DRA) team assist company in planning and managing their pharmaceutical and medical product development programs and regulatory requirements. Biozenta ease the process of obtaining rapid approvals for the products by defining country-specific regulatory strategies early in product development and removing potential roadblocks to a successful product launch.

Biozenta’s Regulatory Services include:

Regulatory team consists of highly qualified personnel engaged in providing data required to assure the high Quality, efficacy and safety of the Products.
Biozenta can provide, Trials data, FDA Certificates and BE Studies for registration of its products as per guidelines of health authorities in most countries.
Biozenta has successfully completed CTD and eCTD submissions for its range of products in various countries.

Events	Dates
Ghana	16-18 May 2023
Belarus (Wegworus)	23-26 May 2023
Uzbekistan (Wegwors)	7-9 June 2023
CPHI & PMEC (Shanghai)	19-21 June 2023
IPHEX Hyderabad	5-7 July 2023
Nigeria (Wegworus)	18-20 July 2023
CPHI Bangkok, Thailand	16-18 August 2023
Iran	27-29 September 2023
CPHI Worldwide (Barcelona)	24-26 October 2023
CPHI & PMEC India	28-30 November 2023

Address

Find Us On Map

Phone

For Business: +91-78070-96339

For Career: +91-78078-36763

biozenta@gmail.com

Get in touch

Corporate Office Address
Biozenta House
7/54 Anand Nagar
Sahayog CO OP HSG SOC LTD
HSG SOC LTD Building no 7
Nehru Road Anand nagar Santacruz East
Mumbai - 400055, India Head Office Address
Biozenta Lifescience Pvt. Ltd.
E-177, Industrial Area, Phase-7
Mohali. 160055 (Punjab), India
Manufacturing Plant (UNIT I)
Biozenta Lifescience Pvt. Ltd.
Khasra No. 59, 60 & 61, Bela Bathri
Haroli, Una, H.P. 174301, India
Mobile: +91-7807096339
Email: biozenta@gmail.com